A study found that the use of GLP-1 drugs for obesity treatment has led to a 25% decrease in weight loss surgeries. The research analyzed data from over 17 million privately insured adults and showed a significant increase in GLP-1 prescriptions, while weight loss surgeries declined. Only 5% of obese patients received GLP-1 drugs, and 0.3% underwent surgery. The study suggests the need for wider adoption of both surgical and pharmacologic treatments for obesity. Concerns were raised about the cost and side effects of GLP-1 medications leading to treatment discontinuation and weight regain. Further research is needed to assess the long-term impact of this shift in treatment strategies.
Source link
GLP-1 Drugs For Obesity Treatment Reduce Bariatric Surgeries By 25%: Study
